Clinical trials
Completed Phase 3 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,965 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 13 |
| 2001 | 34 |
| 2002 | 38 |
| 2003 | 64 |
| 2004 | 84 |
| 2005 | 92 |
| 2006 | 137 |
| 2007 | 141 |
| 2008 | 145 |
| 2009 | 141 |
| 2010 | 163 |
| 2011 | 175 |
| 2012 | 156 |
| 2013 | 159 |
| 2014 | 177 |
| 2015 | 176 |
| 2016 | 144 |
| 2017 | 181 |
| 2018 | 155 |
| 2019 | 152 |
| 2020 | 117 |
| 2021 | 113 |
| 2022 | 78 |
| 2023 | 59 |
| 2024 | 37 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,965 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 153 |
| Novartis Pharmaceuticals | 143 |
| AstraZeneca | 140 |
| GlaxoSmithKline | 116 |
| Pfizer | 115 |
| Sanofi | 109 |
| Eli Lilly and Company | 105 |
| Bristol-Myers Squibb | 85 |
| Novo Nordisk A/S | 77 |
| Janssen Research & Development, LLC | 73 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 172 |
| Asthma | 90 |
| Arthritis, Rheumatoid | 85 |
| Diabetes Mellitus | 77 |
| Carcinoma, Non-Small-Cell Lung | 76 |
| Breast Neoplasms | 75 |
| Pulmonary Disease, Chronic Obstructive | 69 |
| Psoriasis | 58 |
| Epilepsy | 49 |
| Renal Insufficiency, Chronic | 48 |
Trials
Showing 1 to 25 of 2,965. Each trial links to its page on Pharma Observatory.
2,865 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.